Continuous manufacturing could bring the pharmaceutical industry advantages such as improved product quality, easy scale-up, flexibility, and short cycle times. But how can a company switch from batch ...

Alternatives to batch processing finally are starting to be taken seriously by pharmaceutical manufacturers, but the implemention of continuous processing is still in its infancy, and many challenges ...

Most biopharmaceuticals are produced in batches. And, on the manufacturing line, most unit operations are still discrete rather than continuous. For example, the upstream industry has had the option ...

The biopharmaceutical industry has seen substantial growth in recent years, generating novel biotherapeutics and biosimilars at an unprecedented rate. One of the biggest challenges in the industry is ...

When Will Technologies Be Fully Realized? Few biologics today are made using continuous bioprocessing (CBP) equipment but technologies are being developed that improve and link upstream bioreactors ...

Due to their rodent origins, CHO cell lines can harbor endogenous retroviruses or retrovirus-like particles. Additional virus safety risks arise from the potentiality that the cell culture could be ...

Join us in Boston for our annual Flow Chemistry and Continuous Processing Conference, where innovation meets efficiency in the world of chemical and pharmaceutical manufacturing. This cutting-edge ...

Continuous Process Analyzers and Sampling Systems (SP36) teaches students how to select the appropriate technology and components for continuous analyzers and emissions monitoring systems, including ...